Cargando…
Clinical implications of high NQO1 expression in breast cancers
BACKGROUND: NAD (P) H: quinone oxidoreductase 1 (NQO1) is a xenobiotic metabolizing enzyme that detoxifies chemical stressors and antioxidants, providing cytoprotection in normal tissues. However, high-level expression of NQO1 has been correlated with numerous human malignancies, suggesting a role i...
Autores principales: | Yang, Yang, Zhang, Yan, Wu, Qunying, Cui, Xuelian, Lin, Zhenhua, Liu, Shuangping, Chen, Liyan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3944477/ https://www.ncbi.nlm.nih.gov/pubmed/24499631 http://dx.doi.org/10.1186/1756-9966-33-14 |
Ejemplares similares
-
Clinicopathological implications of NQO1 overexpression in the prognosis of pancreatic adenocarcinoma
por: Ji, Meiying, et al.
Publicado: (2017) -
High expression of NQO1 is associated with poor prognosis in serous ovarian carcinoma
por: Cui, Xuelian, et al.
Publicado: (2015) -
β-lapachone suppresses tumour progression by inhibiting epithelial-to-mesenchymal transition in NQO1-positive breast cancers
por: Yang, Yang, et al.
Publicado: (2017) -
Implications of NQO1 in cancer therapy
por: Oh, Eun-Taex, et al.
Publicado: (2015) -
High expression of DEK predicts poor prognosis of gastric adenocarcinoma
por: Piao, Junjie, et al.
Publicado: (2014)